Nationwide Fund Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-6,040
| Closed | -$188K | – | 2344 |
|
|
2017
Q3 | $188K | Buy |
6,040
+1,672
| +38% | +$52K | ﹤0.01% | 2668 |
|
|
2017
Q2 | $138K | Buy |
4,368
+1,206
| +38% | +$38.1K | ﹤0.01% | 2769 |
|
|
2017
Q1 | $72K | Sell |
3,162
-500
| -14% | -$11.4K | ﹤0.01% | 2918 |
|
|
2016
Q4 | $80K | Hold |
3,662
| – | – | ﹤0.01% | 2930 |
|
|
2016
Q3 | $97K | Hold |
3,662
| – | – | ﹤0.01% | 2901 |
|
|
2016
Q2 | $72K | Buy |
+3,662
| New | +$72K | ﹤0.01% | 3019 |
|